Trial Details

RECRUITING
Basic Information
Clinical ID c779
Identifier NCT06064864
Trial Title Efficacy and Safety of Formulation Switching Between SC Infliximab and IV Infliximab in Patients With CD
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Crohn's Disease
Interventions DRUG: Infliximab-Dyyb
Participant Information
Sponsor Asan Medical Center
City Seoul
Country/Region South Korea
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase NA
Time Information
Start Date 2023-10-09
Primary Completion Date 2026-12-31
Completion Date 2026-12-31